US Healthcare Professionals
REDEMPLO® (plozasiran) 25 mg injection is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
CONTRAINDICATIONS: None.
ADVERSE REACTIONS: Most common adverse reactions occurring in ≥10% of REDEMPLO-treated patients are hyperglycemia, headache, nausea, and injection site reaction.